AGENDA
DEPARTMENT OF HEALTH
BOARD OF PHARMACY
COMPOUNDING RULES COMMITTEE MEETING
January 16, 2013
CONFERENCE CALL LINE
(888) 670-3525
Committee Members:
Michele Weizer, PharmD, Chair, Boca Raton
DeAnn Mullins, BPharm, Lynn Haven
Debra B. Glass, BPharm, Tallahassee
Board Staff:
Mark Whitten, Executive Director
Tammy Collins, Program Operations Administrator
Board Counsel:
David Flynn, Assistant Attorney General
Participants in this public meeting should be aware that these proceedings are being recorded.
Wednesday, January 16, 2013 – 9:30 a.m.
TAB 1 RULES & STATUTES
1. Chapter 465.003, Florida Statutes
2. Rule 64B16-27.700, Definition of Compounding
3. Rule 64B16-27.797, Standards for Practice for Compounding Sterile Preparations (CSPs)
4. Rule 64B16-28.100, Pharmacy Permits, Application and Permitting
5. Rule 64B16-28.802
6. Rule 64B16-28.820, Sterile Products and Special Parenteral/Enteral Compounding
7. Rule 64B16-28.840, Special - Non Resident (Mail Service)
TAB 2 SHORT TERM PRIORITIES
1. Low Risk/Medium Risk Compounding verses High Risk Compounding
2. Special Licensing for Sterile Compounding
3. Non-Resident Pharmacy Regulation
a. Accreditation of Sterile Compounding Pharmacies
b. Florida Registered Pharmacist
4. USP 797
No comments:
Post a Comment